Serum lipids, lipoprotein Ip(a), and plasminogen activator inhibitor-1 in patients with Turner's syndrome before and during growth hormone and estrogen therapy

Fertility and Sterility

Volumn 68, Issue 3, 1997, Pages 473-477

  Lanes, Roberto ^a,b   Gunczler, Peter ^b   Palacios, Anselmo ^c   Villaroel, Omar ^d  

^a M 209   (United States)

^b Hospital de Clinicas Caracas   (Venezuela)

^c Clinica Avila   (Venezuela)

^d Hospital Militar Dr Carlos Arvelo   (Venezuela)

Author keywords

Lipoprotein Ip(a); Plasminogen activator inhibitor 1; Serum lipids; Turner's syndrome

Indexed keywords

ESTROGEN; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY RISK; ESTROGEN THERAPY; FEMALE; GROWTH HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; TURNER SYNDROME;

ADOLESCENT; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ESTROGENS, CONJUGATED (USP); FEMALE; GROWTH HORMONE; HUMANS; LIPIDS; LIPOPROTEIN(A); PLASMINOGEN ACTIVATOR INHIBITOR 1; TURNER SYNDROME;

EID: 0030749126     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)00221-5     Document Type: Article

References (17)

1. Ross JI, Feuillan P, Long LM, Kowai K, Kushner H, Cutler GB. Lipid abnormalities in Turner syndrome. J Pediatr 1995; 126:242-5.
2. Wilson DM, Frane JW, Sherman B, Johanson AJ, Hintz RL, Rosenfeld RG, and the Genentech Turner's Collaborative Group. Carbohydrate and lipid metabolism in Turner syndrome: effect of therapy with growth hormone, oxandrolone and a combination of both. J Pediatr 1988; 112:210-7.
3. Rosenfeld R, Frane J, Attie KM, Brasel JA, Burstein S, Cara J, et al. Six year results of a randomized prospective trial of human growth hormone and oxandrolone in Turner syndrome. J Pediatr 1992; 121:49-55.
4. Vanderschueren-Lodeweyckx M, Massa G, Maes M, Craen M, Van Vliet G, Heinrichs C, et al. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome. J Clin Endocrinol Metab 1990; 70: 122-6.
5. Saenger P. Clinical review 48: the current status of diagnosis and therapeutic intervention in Turner's syndrome. J Clin Endocrinol Metab 1993;77:297-301.
6. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-204.
7. Sacks F, Walsh BW. Sex hormones and lipoprotein metabolism. Curr Opin Lipidol 1994;5:236-40.
8. Eden S, Wiklund O, Oscarsson J, Rosen T, Bengstton BA. Growth hormone treatment of growth hormone deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 1993; 13:296-301.
9. Angelin B, Rudling M. Growth hormone and hepatic lipoprotein metabolism. Curr Opin Lipidol 1994;5:160-5.
10. Lobo RA, Notelovitz M, Bernstein L. Lipoprotein(a): relationship to cardiovascular disease risk factor, exercise and estrogen. Am J Obstet Gynecol 1992; 166:1182-90.
11. Marquez A, Mendoza S, Carrasco H, Hamer T, Glueck CJ. High lipoprotein(a) in children from kindred with parental myocardial infarction. Pediatr Res 1993;34:670-4.
12. Olivecrona H, Ericsson S, Berglund L, Angelin B. Increased concentrations of serum lipoprotein(a) in response to growth hormone treatment. Br Med J 1993;306:1726-7.
13. Sprengers ED, Kluft C. Plasminogen-activated inhibitors. Blood 1987;69:381-7.
14. Haukkamaa M, Morgan WT, Koskelo P. Serum histaminerich glycoprotein during pregnancy and hormone treatment. Scand J Clin Lab Invest 1983;43:591-5.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of LDL cholesterol in plasma. Clin Chem 1972; 18:499-502.
16. Svivastana RAK, Baumann D, Schonfeld G. In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse. Eur J Biochem 1993;216:527-38.
17. Kim HJ, Kalkhoff RK. Changes in lipoprotein composition during the menstrual cycle. Metabolism 1979;28:663-8.